Article info
Original research
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
- Correspondence to Dr Oliver Zivanovic, Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; zivanovo{at}mskcc.org
Citation
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
Publication history
- Received August 21, 2020
- Revision received October 22, 2020
- Accepted October 27, 2020
- First published December 3, 2020.
Article Versions
- You are currently viewing a Previous version of this article (3 December 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.